Further, the data show higher tumour expression of CD 200 human genetics correlated with increased clinical benefit indicating CD 200 could be a promising biomarker. We also saw 23andMe 1,473 inhibit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback